Salute e Benessere

Mattress Market Size to Exceed USD 68.5 billion by 2031, with a Strong CAGR of…

Changing lifestyles and demographic shifts, particularly among younger consumers, influence preferences for customizable and multi-functional mattresses that cater to diverse sleep needs. The increasing focus on sleep ergonomics and design innovation drives the demand for mattresses that offer superior comfort and support, enhancing sleep quality. Changing lifestyles and demographic shifts, particularly among younger consumers, influence preferences for customizable and multi-functional...
PR Newswire
05/12/2023

Hospital Services Market Size Estimated to Reach USD 21,529.2 Billion by 2032

Global Hospital Services Market Size and Y-O-Y Forecasted (2022 to 2032) Global Hospital Services Market Size and Y-O-Y Forecasted (2022 to 2032) The Full Study is Readily Available | Download the Sample Pages of this Report@https://www.precedenceresearch.com/sample/1082 Hospital Services Market Revenue ($ Billion), By Hospital Type Hospital services are diverse and essential components of the healthcare system, that includes a wide range of offerings to address...
PR Newswire
05/12/2023

Global Orthopedic Devices Market to Reach USD 53.33 Billion by 2030, Recording a…

Request Sample PDF of the Report: https://www.kingsresearch.com/request-sample/orthopedic-devices-market-171 Request Sample PDF of the Report:https://www.kingsresearch.com/request-sample/orthopedic-devices-market-171 Trending Now: Tyber Medical, Orthopedic Device Manufacturer, Expands Florida Facility Tyber Medical LLC, headquartered inBethlehemand a global leader in private-label medical devices for major orthopedic companies, announced its plan to enlarge itsBonita Springs,...
PR Newswire
05/12/2023

Kidney Transplant Market to Surpass US$ 106.18 Billion by 2028 - Coherent Market…

Growing focus of major market players on adoption of various growth strategies is one of the major trends in the global kidney transplant market. Key players are adopting strategies such as collaborations, acquisitions, and mergers, and product approvals. For instance, In September 2021, Sanofi, and Kadmon Holdings, Inc. announced partnership, which supports Sanofi's strategy to boost its main assets of general medicines. Moreover, in April 2021, Farxiga (Dapagliflozin) received approval from…
PR Newswire
05/12/2023

FeelTect receive top prize at Lohmann & Rauscher (L&R) Accelerator Program for…

Amongst a highly competitive field, FeelTect emerged as the overall winner of the program for their collaborative project involving their pioneering Tight Alright technology – the first connected-health technology for measuring and remotely monitoring sub-bandage pressure during compression therapy, primarily for the millions of people world-wide with venous leg ulcers. The Tight Alright technology is comprised of a wearable device with multiple pressure sensors that wirelessly connects with a…
PR Newswire
05/12/2023

Director/PDMR Shareholding

DXS INTERNATIONAL PLC Notification of Director / PDMR DealingThe Board of DXS International plc (the “Company”), the AQSE Growth Market quoted clinical decision support developer and supplier of clinical decision support systems has received notification and notified the market that on 4 December 2023 Mr Bob Sutcliffe purchased a total of 400,000 Ordinary Shares in the Company at a price of 2.5p per share on behalf of himself and others.One of the other persons acquiring beneficial...
Nasdaq GlobeNewswire
05/12/2023

Director/PDMR Shareholding

DXS INTERNATIONAL PLC Notification of Director / PDMR DealingThe Board of DXS International plc (the “Company”), the AQSE Growth Market quoted clinical decision support developer and supplier of clinical decision support systems has received notification that on 4 December 2023 Mr Bob Sutcliffe purchased a total of 400,000 Ordinary Shares in the Company at a price of 2.5p per share on behalf of himself and others.Mr Sutcliffe's interest in the transaction was acquiring 180,000 Ordinary...
Nasdaq GlobeNewswire
05/12/2023

Internet of Medical Things Market revenue to hit USD 516.40 Billion by 2033…

Chronic diseases such as heart disease, diabetes, and cancer are becoming increasingly common, particularly as the population ages. Internet of Medical Things devices can be used to monitor patients with chronic diseases remotely, helping to prevent complications and improve patient outcomes. Chronic diseases such as heart disease, diabetes, and cancer are becoming increasingly common, particularly as the population ages. Internet of Medical Things devices can be used to monitor patients with...
PR Newswire
05/12/2023

Driven by Home Dialysis Trend, US Dialysis Equipment Market to Reach US$ 8,690.2…

Get an Exclusive Sample Copy of the Dialysis Equipment Sales in the US, 2024-2034: https://www.futuremarketinsights.com/reports/sample/rep-gb-18512 Get an Exclusive Sample Copy of the Dialysis Equipment Sales in the US, 2024-2034:https://www.futuremarketinsights.com/reports/sample/rep-gb-18512 Several factors are expected to stimulate the growth ofthe United Statesdialysis equipment business. These include the rising prevalence of kidney diseases, growing trends toward...
PR Newswire
05/12/2023

Health Information Exchange Market to Reach $3.8 Billion, Globally, by 2032 at…

Request Sample of the Report on Health Information Exchange Market Forecast 2032- https://www.alliedmarketresearch.com/request-sample/7658 Request Sample of the Report on Health Information Exchange Market Forecast 2032- https://www.alliedmarketresearch.com/request-sample/7658 Prime determinants of growth Rise in adoption of cloud technology in healthcare services, growing focus on patient-centric care delivery, and advancements in health information exchange drive the growth...
PR Newswire
05/12/2023

Candle Market Size to be Worth USD 16.9 billion by 2031, With a CAGR of 6.5% |…

Rising concerns about air quality have propelled the demand for clean-burning candles made from natural materials like soy or beeswax. Consumers are increasingly seeking candles devoid of harmful chemicals like paraffin, aligning with health-conscious choices. Rising concerns about air quality have propelled the demand for clean-burning candles made from natural materials like soy or beeswax. Consumers are increasingly seeking candles devoid of harmful chemicals like paraffin, aligning with...
PR Newswire
05/12/2023

Medical Stick-to-Skin Adhesives Market Worth $3.7 Billion | MarketsandMarkets

Browse in-depth TOC on "Medical Stick-to-Skin Adhesives Market" Browse in-depth TOC on "Medical Stick-to-Skin Adhesives Market" 213 - Tables 51 - Figures 273 - Pages Medical Stick-to-Skin Adhesives Market Scope: Moreover, a growing emphasis on patient comfort and convenience is fueling the development of skin-friendly adhesives that offer secure attachment without causing irritation or damage. The rise of wearable medical devices, such as continuous glucose monitors...
PR Newswire
05/12/2023

Anthelmintic Drugs Market to Reach $1.5 billion, globally, by 2032 at 3.8% CAGR…

Request Sample of the Report on Anthelmintic Drugs Market Forecast 2032- https://www.alliedmarketresearch.com/request-sample/11866 Request Sample of the Report on Anthelmintic Drugs Market Forecast 2032-https://www.alliedmarketresearch.com/request-sample/11866 Prime determinants of growth Key factors driving the growth of the anthelmintic drugs market include rise in incidences of parasitic infections, increase in awareness of preventive measures against Helminth infections,...
PR Newswire
05/12/2023

RNA- Based Therapeutic Market worth $29.41 Bn by 2031 - Exclusive Report by…

RNA- Based Therapeutic Market Report Scope RNA- Based Therapeutic Market Report Scope Request for Free Sample:https://www.insightaceanalytic.com/report-details/global-rna-based-therapeutics-market-assessment/ RNA based therapy is a more efficient and accurate treatment strategy that modifies the faulty gene product by targeting RNA precursors using inherent therapies. Various biotech and pharmaceutical companies are developing RNA-based therapeutics to precisely regulate...
PR Newswire
05/12/2023

Dragonfly Therapeutics Initiates Phase 1/1b Study of its IL-2 Immunotherapy in…

"DF6215's therapeutic potential is particularly compelling," said Dr. Benedito A. Carneiro, MD, MS, Associate Director of the Hematology/Oncology Division, Director of the Phase I program at the Lifespan Cancer Institute, and Co-Leader of the Cancer Therapeutics Program at the Legorreta Cancer Center at Brown University. "Dragonfly's IL-2 preclinical package shows strong anti-tumor activity in cold and hot tumor models and a favorable therapeutic window in cyno, with no signs of…
PR Newswire
05/12/2023

Affidea expands its presence in Europe with acquisitions in Spain and Romania

Guy Blomfield, Chairman and CEO of Affidea Group, commented on this milestone, saying, "Affidea has significantly expanded its presence in 2023, completing a total of 14 acquisitions in eight countries, adding 25 new centres. Today, we are thrilled to extend our presence in Spain and Romania, two markets with great potential. These latest acquisitions mark a significant step in our ongoing growth journey, reaching today more than 340 centres across 15 countries, annually serving over 13…
PR Newswire
05/12/2023

Global Typhoid Challenges in Focus at International Conference in Rwanda

KIGALI, Rwanda, Dec.05, 2023(GLOBE NEWSWIRE) -- The 13 thInternational Conference on Typhoid & Other Invasive Salmonelloses gets under way today in Kigali, Rwanda, with nearly 350 researchers, healthcare professionals and policymakers meeting to find ways to address the urgent challenges of typhoid and other invasive salmonelloses.The three-day conference, hosted by the Coalition against Typhoid (CaT), housed at the Sabin Vaccine Institute, is the largest convening of the...
Nasdaq GlobeNewswire
05/12/2023

Curia Recognized on India Pharma Outlook's 2023 List of Top 10 CDMO Companies in…

November 2023 edition of the India Pharma Outlook magazine. This recognition acknowledges the contributions of Curia's Aurangabad and Hyderabad sites. The Aurangabad facility provides contract manufacturing of active pharmaceutical ingredients (APIs) and intermediates, and the Hyderabad site includes the Hyderabad Research Center with expertise in medicinal chemistry and chemical and analytical development. These sites also house Curia's quality control center and Global Shared Services...
Nasdaq GlobeNewswire
05/12/2023

Versameb Names Dr. Alexandre LeBeaut as Chair of the Board of Directors

Dr. Alexandre LeBeaut, new Chairman of the Board of Directors of Versameb, commented: "I am honored to take this responsibility as Chair of Versameb's board at such a pivotal time in company's growth trajectory. Through the development of its unique and proprietary VERSagile platform the company can target the biology of diseases with unmet medical needs and to have the potential to transform patients' lives. This is particularly relevant for VMB-100 which is set to enter Phase 2a open…
PR Newswire
05/12/2023

Merck Launches First Ever AI Solution to Integrate Drug Discovery and Synthesis

"With millions of people waiting for the approval of new medicines, bringing a drug to market, still takes on average, more than 10 years and costs over 1.9 billion Euros1" said Karen Madden, Chief Technology Officer, Life Science business sector of Merck. "Our platform enables any laboratory to count on generative AI to identify the most suitable drug-like candidates in a vast chemical space. This helps ensure the optimal chemical synthesis route for development of a target…
PR Newswire
05/12/2023

Evolution Optiks Successfully Completes Data Collection in Clinical Study of…

DeCon, the flagship product of the NeuroDynamiks™ brand of Evolution Optiks, is a portable head-mounted device that uses proprietary light field technology to track and analyze involuntary movements of the eyeball in response to visual stimuli and positional changes. This is essential in the diagnosis of vestibular disorders which are commonly caused by external trauma to the brain such as a fall, a blow or jolt to the head. DeCon can perform dozens of established neurological tests, the results…
PR Newswire
05/12/2023

ClariMed Opens New Office in Cambridge, MA, Expanding its Reach in the Heart of…

The office is also pivotal to ClariMed's talent acquisition plans. "Boston's academic landscape is a powerhouse of talent and innovation. This location enables us to tap into a diverse pool of skilled professionals across Massachusetts and extending into New Hampshire," added Bergquist. The office is also pivotal to ClariMed's talent acquisition plans. " Boston'sacademic landscape is a powerhouse of talent and innovation. This location enables us to tap into a diverse pool of…
PR Newswire
05/12/2023

SkylineDx Announces Commercial Collaboration with Tempus to Advance Patient Care…

"We are excited to embark on this new collaboration with Tempus," said Dharminder Chahal, CEO of SkylineDx. "Their reputation for innovation and commitment to improving patient outcomes aligns perfectly with our vision. This partnership is one of the key pillars of our commercialization strategy that aims to bring the SkylineDx Merlin™ Test to a wider audience, ensuring that more melanoma patients have access to personalized treatment options that can significantly impact their…
PR Newswire
05/12/2023

Diabetes Management Apps Market to Record an Exponential CAGR of 24.4% by 2031 -…

Diabetes Management Apps Market Report Scope Diabetes Management Apps Market Report Scope Request for Free Sample Pages: https://www.insightaceanalytic.com/request-sample/1310 The use of smartphone applications for the self-management of chronic illnesses has shown promise. The diabetes management applications platform solution is used by people with various types of diabetes or pre-diabetes to monitor and manage their condition. The inability of the pancreas to produce...
PR Newswire
05/12/2023
Altri  Comunicati